Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cem Boruban
Lapatinib Plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience
Breast Care
Surgery
Oncology
Synchronous Presentation of Nasopharyngeal and Renal Cell Carcinomas
International braz j urol : official journal of the Brazilian Society of Urology
Medicine
Urology
Related publications
Lapatinib Plus Capecitabine in Women With HER-2-Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial
Oncologist
Cancer Research
Medicine
Oncology
An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Preliminary Safety Data of Preoperative Chemotherapy Plus Trastuzumab, Lapatinib or Both in HER2-positive Operable Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Phase I Study of Intermittent High Dose Lapatinib Alternating With Capecitabine for HER2-positive Breast Cancer Patients With Central Nervous System Metastases
Clinical Cancer Research
Cancer Research
Oncology
Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
New England Journal of Medicine
Medicine
Optimal Treatment of Early Stage HER2-positive Breast Cancer
Cancer
Cancer Research
Oncology
HER2-positive Breast Cancer With Brain Metastasis, Long Responder to Lapatinib Therapy
AboutOpen
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
